MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MYGN on Nasdaq
CUSIP
62855J104
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
93.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
88.5M
Holdings value
$640M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
210
Number of buys
108
Number of sells
-107
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.3% $56.8M 14.1M BlackRock, Inc. Jun 30, 2025
VANGUARD GROUP INC 8.47% -15.7% $57M -$9.94M 7.88M -14.9% The Vanguard Group Sep 30, 2025
INTEGRATED CORE STRATEGIES (US) LLC 5.1% -4% $34.3M -$1.28M 4.75M -3.58% Millennium Management LLC Sep 30, 2025
BARCLAYS PLC 4.23% -21.6% $28.5M -$6.95M 3.94M -19.6% Barclays PLC Sep 30, 2025
Camber Capital Management LP 3.41% $26.2M 3.1M Camber Capital Management LP Dec 31, 2024
DISCIPLINED GROWTH INVESTORS INC /MN 0.8% -86% $4.54M -$21.3M 754K -82.4% DISCIPLINED GROWTH INVESTORS INC /MN Jun 30, 2025

Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 88.5M $640M +$7.17M $7.23 210
2025 Q2 90.5M $481M -$73.9M $5.31 217
2025 Q1 94M $833M +$10.2M $8.87 226
2024 Q4 92.4M $1.27B -$38.6M $13.71 215
2024 Q3 90.7M $2.48B -$47M $27.39 242
2024 Q2 92.3M $2.26B -$38.8M $24.46 222
2024 Q1 93.8M $2B +$66.1M $21.32 185
2023 Q4 65.7K $1.26M -$1.37M $19.14 2
2023 Q3 82.7M $1.33B +$18.6M $16.04 182
2023 Q2 81.1M $1.88B -$25.4M $23.18 183
2023 Q1 82.2M $1.91B +$45.6M $23.23 186
2022 Q4 80.3M $1.17B -$18.1M $14.51 188
2022 Q3 81.3M $1.55B +$29.7M $19.08 180
2022 Q2 79.9M $1.45B +$16.6M $18.17 183
2022 Q1 78.9M $1.99B +$13.5M $25.20 198
2021 Q4 78.3M $2.16B -$42M $27.60 189
2021 Q3 79.3M $2.56B +$119M $32.29 208
2021 Q2 75.5M $2.31B +$49.4M $30.58 199
2021 Q1 73.9M $2.25B -$33.4M $30.45 194
2020 Q4 74.8M $1.48B +$41M $19.78 174
2020 Q3 77.4M $1.01B +$16.4M $13.04 180
2020 Q2 72.9M $826M -$37.2M $11.34 185
2020 Q1 72.3M $1.04B -$107M $14.31 178
2019 Q4 78.6M $2.14B +$33.2M $27.23 213
2019 Q3 77.3M $2.21B +$28.9M $28.63 213
2019 Q2 76.6M $2.13B -$35.5M $27.78 227
2019 Q1 78.4M $2.6B +$91.7M $33.20 254
2018 Q4 75.8M $2.2B +$4.44M $29.07 254
2018 Q3 75.2M $3.46B +$104M $46.00 274
2018 Q2 73.2M $2.74B -$3.85M $37.37 244
2018 Q1 74.8M $2.21B +$13.6M $29.55 248
2017 Q4 74.6M $2.56B -$23.6M $34.34 240
2017 Q3 74.4M $2.69B -$243M $36.18 210
2017 Q2 81.8M $2.11B -$23.7M $25.84 232
2017 Q1 83.4M $1.6B +$191M $19.20 229
2016 Q4 79.8M $1.33B -$62.9M $16.67 217
2016 Q3 82.7M $1.7B -$42.4M $20.58 217
2016 Q2 81.1M $2.48B -$38.6M $30.60 250
2016 Q1 81.7M $3.06B -$306M $37.43 226
2015 Q4 89.6M $3.87B -$59.1M $43.16 226
2015 Q3 90.4M $3.39B -$73.2M $37.48 228
2015 Q2 92.3M $3.14B -$20.8M $33.99 231
2015 Q1 92.6M $3.28B -$49.8M $35.40 250
2014 Q4 93.5M $3.19B -$76.1M $34.06 262
2014 Q3 95.4M $3.68B -$223M $38.57 269
2014 Q2 101M $3.93B -$204M $38.92 279
2014 Q1 108M $3.68B +$241M $34.19 274